Published in J Hyg (Lond) on September 01, 1966
Isolation of shigellae. VI. Performance of media with stool speciments. Appl Microbiol (1968) 1.27
Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines. Infect Immun (1994) 1.25
The diagnosis of salmonella abortion in cattle with particular reference to Salmonella dublin. A review. J Hyg (Lond) (1977) 1.03
The effect of time in lairage on the frequency of salmonella infection in slaughtered pigs. J Hyg (Lond) (1982) 0.94
The occurrence of Salmonella infection in market swine in Southwestern Ontario. Can Vet J (1971) 0.84
Age susceptibility and excretion of Salmonella typhimurium in calves. J Hyg (Lond) (1968) 0.78
Prevalence of Salmonella Excretion in Stool: A Community Survey in 2 Sites, Guinea-Bissau and Senegal. Clin Infect Dis (2016) 0.75
The numbers of pathogenic bacilli in faeces in intestinal diseases. J Hyg (Lond) (1955) 4.25
Comparative efficiency of rectal swabs and fecal specimens in detecting typhoid and Salmonella cases and carriers. Am J Public Health Nations Health (1948) 1.83
Isolation of the Legionnaires' disease bacterium from environmental samples. Ann Intern Med (1979) 7.69
Antiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosa. Infect Immun (1971) 4.18
Legionella gormanii sp. nov. J Clin Microbiol (1980) 4.12
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci (1967) 3.17
Proliferation of Legionella pneumophila as an intracellular parasite of the ciliated protozoan Tetrahymena pyriformis. Appl Environ Microbiol (1984) 3.02
Isolation of Salmonella typhi-murium from municipal water, Riverside, California, 1965. Am J Epidemiol (1971) 2.59
Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53
Isolation of protozoa from water associated with a legionellosis outbreak and demonstration of intracellular multiplication of Legionella pneumophila. Appl Environ Microbiol (1986) 2.52
Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46
Selective enrichment broth medium for isolation of Campylobacter jejuni. J Clin Microbiol (1983) 2.26
Characterization of an unusual strain of proteus rettgeri associated with an outbreak of nosocomial urinary-tract infection. Appl Microbiol (1971) 2.01
Lincomycin: activity in vitro and absorption and excretion in normal young men. Am J Med Sci (1967) 2.00
New biological activity following intravascular activation of the complement cascade. Nature (1974) 1.89
Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest (1972) 1.85
Comparison of arbitrarily primed polymerase chain reaction, ribotyping, and monoclonal antibody analysis for subtyping Legionella pneumophila serogroup 1. J Clin Microbiol (1993) 1.82
Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem (2000) 1.78
Epidemic salmonellosis from cheddar cheese: surveillance and prevention. Am J Epidemiol (1980) 1.72
Dissociation by colchicine of the hexose monophosphate shunt activation from the bactericidal activity of the leukocyte. Infect Immun (1971) 1.64
An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes. J Clin Invest (1975) 1.63
Superoxide dismutase activity in leukocytes. J Clin Invest (1974) 1.59
Characterization of an axenic strain of Hartmannella vermiformis obtained from an investigation of nosocomial legionellosis. J Protozool (1991) 1.56
1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. Am J Pathol (1981) 1.56
Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest (1991) 1.54
Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med (1969) 1.53
Detection of pulmonary tuberculosis in patients with a normal chest radiograph. Chest (1999) 1.52
Genital Chlamydia infections in sexually active female adolescents: do we really need to screen everyone? J Adolesc Health (1997) 1.50
Interstate outbreak of Salmonella newbrunswick infection traced to powdered milk. JAMA (1968) 1.50
Hospitalizations involving gastroenteritis in the United States, 1985: the special burden of the disease among the elderly. Am J Epidemiol (1992) 1.48
Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1966) 1.48
A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med (1994) 1.47
Two outbreaks of egg-borne salmonellosis and implications for their prevention. JAMA (1967) 1.45
Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol (1986) 1.45
Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest (1980) 1.44
Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor. J Clin Invest (1986) 1.44
Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis (1975) 1.43
Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J Biol Chem (1989) 1.42
Functional characteristics of human toxic neutrophils. J Infect Dis (1971) 1.41
Effects of transport temperature and medium on recovery of Bordetella pertussis from nasopharyngeal swabs. J Clin Microbiol (1988) 1.39
Risk factors for self-reported uterine fibroids: a case-control study. Am J Public Health (1996) 1.36
Isolation of Pittsburgh pneumonia agent from nebulizers used in respiratory therapy. Ann Intern Med (1980) 1.36
Association of flagellum expression and intracellular growth of Legionella pneumophila. Infect Immun (1995) 1.28
Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes. J Immunol (1978) 1.27
Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem (1992) 1.26
Magnesium-dependent adenosine triphosphatase as a marker enzyme for the plasma membrane of human polymorphonuclear leukocytes. Infect Immun (1977) 1.25
Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem Biophys Res Commun (1992) 1.25
Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest (1980) 1.24
Phagocytosis of live versus heat-killed bacteria by human polymorphonuclear leukocytes. Infect Immun (1974) 1.22
Characterization of the human interleukin 1 receptor on human polymorphonuclear leukocytes. Clin Immunol Immunopathol (1988) 1.20
The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men. Clin Immunol Immunopathol (1991) 1.20
The effects of ascorbic acid on bactericidal mechanisms of neutrophils. J Infect Dis (1971) 1.19
Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest (1990) 1.19
Priming of the respiratory burst of neutrophils by diacylglycerol. Independence from activation or translocation of protein kinase C. J Biol Chem (1987) 1.17
Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease. J Clin Invest (1988) 1.16
Selective desensitization of neutrophils: further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues. J Immunol (1981) 1.15
Increased recovery of Legionella micdadei and Legionella bozemanii on buffered charcoal yeast extract agar supplemented with albumin. J Clin Microbiol (1990) 1.14
Fatal nosocomial Legionnaires' disease: clinical and epidemiologic characteristics. Ann Intern Med (1979) 1.13
Protocol for sampling environmental sites for legionellae. Appl Environ Microbiol (1987) 1.13
Reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate diaphorase activity in human polymorphonuclear leukocytes. Infect Immun (1974) 1.12
Growth of bacteria and fungi in total parenteral nutrition solutions. Am J Surg (1973) 1.12
Anaphylactic actions of platelet-activating factor. Am J Pathol (1981) 1.12
Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung. Am J Pathol (1980) 1.11
Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents. Am J Pathol (1981) 1.11
Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. J Immunol (1991) 1.11
Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol (1994) 1.10
Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase. J Clin Invest (1991) 1.10
Stimulation of the hexose monophosphate shunt in human neutrophils by ascorbic acid: mechanism of action. Antimicrob Agents Chemother (1972) 1.08
Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C. J Biol Chem (1992) 1.08
Raw hamburger: an interstate common source of human salmonellosis. Am J Epidemiol (1978) 1.08
Tumor necrosis factor alpha priming of phospholipase D in human neutrophils. Correlation between phosphatidic acid production and superoxide generation. J Biol Chem (1991) 1.07
Deficiency of NADPH oxidase activity in chronic granulomatous disease. J Pediatr (1977) 1.05
Nitroblue tetrazolium reduction. False positive and false negative results. Blood (1973) 1.05
Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections. Antimicrob Agents Chemother (1983) 1.04
Human toxic neutrophils. 3. Metabolic characteristics. J Infect Dis (1973) 1.03
Salmonellae in fish meal plants: relative amounts of contamination at various stages of processing and a method of control. Appl Microbiol (1970) 1.03
Differentiation between vibrio cholerae and Vibrio cholerae biotype El Tor by the polymyxin B disc test: comparative results with TCBS, Monsur's, Mueller-Hinton and nutrient agar media. Bull World Health Organ (1967) 1.02
Stimulation of oxidative metabolism in polymorphonuclear leukocytes by catecholamines. J Reticuloendothel Soc (1972) 1.02
Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids. Am J Pathol (1981) 1.02
Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine. J Immunol (1987) 1.01
An interstate outbreak of salmonellosis traced to a contaminated food supplement. Am J Epidemiol (1966) 1.01
The generation of superoxide anion by various types of phagocyte. J Infect Dis (1975) 1.01
Enhancement of hexose uptake in human polymorphonuclear leukocytes by activated complement component C5a. Proc Natl Acad Sci U S A (1979) 1.00
The in vitro effect of steroids on polymorphonuclear leukocyte metabolism. Proc Soc Exp Biol Med (1972) 1.00
Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis (1992) 0.99
Leucocyte G.-6-P.D. deficiency. Lancet (1970) 0.99
Diacylglycerols enhance human neutrophil degranulation responses: relevancy to a multiple mediator hypothesis of cell function. Biochem Biophys Res Commun (1984) 0.99
Stimulation of leukocyte hexose monophosphate shunt activity by ascorbic Acid. Infect Immun (1971) 0.98
Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation. Biochem Biophys Res Commun (1981) 0.98
Hexose monophosphate shunt activity and oxygen consumption during phagocytosis: temporal sequence. 1. Proc Soc Exp Biol Med (1972) 0.98
Purification of plasma membrane from BCG-induced rabbit alveolar macrophages. J Reticuloendothel Soc (1976) 0.98
Topical antimicrobials applied to the umbilical cord stump: a new intervention against neonatal tetanus. Int J Epidemiol (1998) 0.97
Phosphatidic acid and diacylglycerol synergize in a cell-free system for activation of NADPH oxidase from human neutrophils. J Biol Chem (1993) 0.97
Waterborne shigellosis at a public school. Am J Epidemiol (1975) 0.97
Protein-tyrosine kinase activation is required for lipopolysaccharide induction of interleukin 1beta and NFkappaB activation, but not NFkappaB nuclear translocation. J Biol Chem (1996) 0.97
The associations of alcohol drinking and drinking cessation to measures of the immune system in middle-aged men. Alcohol Clin Exp Res (1992) 0.96
Lipoxygenbase-derived products of arachidonic acid mediate stimulation of hexose uptake in human polymorphonuclear leukocytes. Biochem Biophys Res Commun (1981) 0.94
In vitro responses of human neutrophils to N-formyl-methionyl-leucyl-phenylalanine: correlation with effects of acute bacterial infection. J Infect Dis (1979) 0.94
Histopathologic features of phorbol myristate acetate-induced lung injury. Lab Invest (1985) 0.93
Endotoxin inducible transcription is repressed in endotoxin tolerant cells. Shock (2000) 0.93